🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Genomic Sequencing in Anatomically Normal Fetuses

RecruitingNAAges 18 Years - 64 YearsAllUniversity of California, San Francisco
NCT06211348 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Pregnant patients who are: * Pregnant with a structurally normal fetus (singleton or multiple gestation) * Planning to undergo prenatal diagnosis by either chorionic villus sampling or amniocentesis with chromosome microarray analysis for routine indications * Planning, or have already completed expanded carrier screening Exclusion Criteria: Pregnant patients who: * Decline prenatal diagnostic testing * Are pregnant and their fetus has a known anomaly * Declined chromosomal microarray analysis of expanded carrier screening
💊

What it tests

  • Genomic Sequencing
📍

Where

1 site
University of California, San Francisco
San Francisco, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy